NEW YORK (GenomeWeb News) – Sigma-Aldrich this week announced that it has named a new CFO and has shuffled some of its management team.
The firm said that Rakesh Sachdev will take over as CFO effective Nov. 17, succeeding Mike Hogan, who announced earlier this year his plan to retire. Sachdev previously served as SVP of corporate development and strategy, corporate controller, and interim CFO of ArvinMentor.
In other organizational changes that will be come effective Jan. 1, Sigma-Aldrich said that Karen Miller, currently controller, will be promoted the newly created position of VP of strategy and corporate development. Dave Julian, currently president of research specialties, will become president of supply chain, also a newly created role. Frank Wicks, currently president of the SAFC division, will become president of research specialties. Finally, Giles Cottier, who is serving as president of research essentials, will become president of SAFC.
Medbiogene has appointed Vineet Bansal to be director of product launch and marketing, and has appointed Debbie Corazzelli as senior advisor of diagnostics commercialization. Both had previously worked at XDx and were involved with that company’s gene expression-based test.
Coda Genomics has tapped Stephen Picataggio to serve as chief scientific officer. Picataggio has been VP of metabolic engineering at Synthetic Genomics, and he worked in various posts at Dupont Central Research and Development, at the National Renewable Energy Laboratory, and at Cognis.
MDRNA has hired Barry Polisky to be chief scientific officer. He will replace Steven Quay, who will continue on the company’s board of directors and its scientific advisory board. Polisky formerly was VP of R&D at Merck, and CSO at Sirna Therapeutics.
Accelrys has appointed Larry Ferguson to its board of directors. Ferguson served as CEO of First Consulting Group, until that firm’s acquisition earlier this year by Computer Sciences Corporation. He also previously served as chairman of Daou Systems.
IO Informatics has named several new members to its scientific advisory board. The new members include Jack Rollins, who is manager of scientific computing and program development for the Advanced Biomedical Computing Center, which is run by SAIC-Frederick; Johann Bauer, who is scientific information manager at the Max Planck Institute; Sangtae Kim, who is executive director of the Morgridge Institute for Research; and Robert Stevenson, who is founder and principal of the Abacus Group.
New England Peptide has tapped three new members for its scientific advisory board including Vincent Bille, Tomi Sawyer, and Ved Srivastava. Bille is a founder and principal of Marble Pharma Consulting. Sawyer is currently chief scientific officer at Aileron Therapeutics, and he formerly was senior director at the Pfizer Research Technology Center. Srivastava is associate director of discovery research at Amylin Pharmaceuticals.
Arthur Pappas, who is founder and managing partner of the Research Triangle Park, NC-based venture capital firm Pappas Ventures, has been named chairman of the North Carolina Biotechnology Center. Pappas formerly was a member of the board of directors at Glaxo Holdings, and he was VP for commercial operations at, among other positions. He succeeds Sue Cole, of Granville Capital, as chairman of the NCBC.
The Arizona Technology Council has appointed Michael Berens and MaryAnn Guerra of the Translational Genomics Research Institute to its board of directors. The Council also has named nine other new directors including David Beauchamp, partner, Bryan Cave; Thomas Campbell, partner, Lewis and Roca; Kathleen Collins, functional chief engineer, Boeing; John Cummerford, shareholder, Intellectual Property & Technology, and Technology, Media & Telecommunications, Greenburg Traurig; Joe Drazek, partner, Quarles and Brady; Carl Lytikainen, senior vice president of technical services, Lumension Security; Jane Poynter, president, Paragon Space Development Corporation; Rick Shangraw, VP for research and economic affairs, Arizona State University; and Judith Weiss, partner, Perkins Coie Brown & Bain.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.